Idiopathic pulmonary fibrosis - Open Access .click

Results 221 to 230 of about 73,124 (298)

Urinary Collagen Peptides Predict Mortality

PROTEOMICS, Volume 26, Issue 7, Page 98-110, July 2026.
ABSTRACT Organ fibrosis caused by the presence of excessive extracellular matrix (ECM) is related to mortality. Urinary peptide signatures were reported to be predictive of death in SARS‐CoV‐2 and chronic kidney disease. Such signatures were composed for 68% of collagen fragments.
Maria Frantzi +15 more
wiley +1 more source

Lung transplant outcomes in myositis, systemic sclerosis and idiopathic pulmonary fibrosis: a multicentre retrospective analysis. [PDF]

Rheumatology (Oxford)
Chang A +12 more
europepmc +1 more source

Usual Interstitial Pneumonia in a Patient With Celiac Disease: Expanding the Spectrum of Pulmonary Manifestations

Respirology Case Reports, Volume 14, Issue 7, July 2026.
This case highlights a rare association between usual interstitial pneumonia and celiac disease, broadening the recognized spectrum of pulmonary involvement beyond Lane–Hamilton syndrome. It emphasizes the importance of considering celiac disease in the evaluation of fibrosing interstitial lung disease, particularly when gastrointestinal symptoms are ...
Ragini Gopagoni +6 more
wiley +1 more source

Clinical and genetic features of idiopathic pulmonary fibrosis in a Korean cohort. [PDF]

Respir Res
Kim C +5 more
europepmc +1 more source

Deep‐Learning Algorithm Diagnostic Support for Usual Interstitial Pneumonia Pattern Recognition in Fibrotic Interstitial Lung Disease

Respirology, Volume 31, Issue 7, Page 711-720, July 2026.
ABSTRACT Background and Objective High resolution computed tomography (HRCT) scan diagnostic classification for usual interstitial pneumonia (UIP) plays a critical role in therapeutic decision‐making and clinical trial eligibility for interstitial lung disease (ILD) patients, but is subject to variability.
Caitlin C. Fermoyle +313 more
wiley +1 more source

Determinants of Improved Dyspnea and Exercise Tolerance With Nasal High‐Flow O2 Therapy in Fibrotic Interstitial Lung Disease: A Pilot Physiological Study

Respirology, Volume 31, Issue 7, Page 732-744, July 2026.
We tested the respective effect of high‐flow and supplemental O2 from nasal high‐flow O2 therapy (NHFO2) on dyspnea and exercise tolerance in fibrotic interstitial lung disease. Supplemental O2 and NHFO2 (but not high‐flow) provided improvements in these outcomes at “iso‐O2 saturation” due to reduced ventilatory requirements.
Sarah Thivent +4 more
wiley +1 more source

The rise and fall of glucocorticoids and immunosuppressants in idiopathic pulmonary fibrosis: a historical paradigm shift driven by mechanistic understanding. [PDF]

Front Immunol
Wen B, Wu X, Ma X, Li D, Qian L.
europepmc +1 more source

An Age‐Friendly Approach to Caring for Chronic Lung Disease in the Ambulatory Setting

Respirology, Volume 31, Issue 7, Page 676-692, July 2026.
ABSTRACT Many common chronic lung diseases, such as chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD), have much greater prevalence among older adults and as a result, pose a substantial burden of morbidity, disability, and mortality. The care of older adults with chronic lung disease necessitates an age‐friendly approach
Angela O. Suen +3 more
wiley +1 more source

humans
3. good health
pulmonary fibrosis

prognosis
lung
medicine

lung transplantation
tomography, x-ray computed
female